TAO SYNERGIES INC
TAOXNASDAQπ #4697 by market capEarnings Mar 3US Equity
$1.55βΌ $0.18 (β10.40%)
Market closed Β· at closeTrack TAOX
Get earnings, price moves & breaking news on Telegram
24hβΌ 10.4%
7dβΌ 24.4%
14dβΌ 37.5%
30dβΌ 53.6%
ytdβΌ 58.3%
1yβΌ 75.9%
π¦Market Cap
$12M
Small Cap
πRevenue Growth (YoY)
β
πGross Margin
β
π΅FCF Margin
β
βοΈP/S Ratio
16.1x
Expensive
Otter Score
β
Insufficient data
Trading Snapshot
- Day Range
- $1.50 β $1.74
- 52-Week Range
- $1.50 β $7.85
- Volume (shares)
- 230,473
- Avg Volume (shares)
- β
- Shares Outstanding
- 7.5M
- Next Earnings
- 2027-03-03
Fundamentals Snapshot
- Annual Revenue
- $299,061
- Last Q Revenue
- $88,626
- P/E Ratio
- β
- P/S Ratio
- 16.1x
- EPS (TTM)
- $-3.38
- Dividend Yield
- 5.04%
- Dilution (1yr)
- +448.8%
TAO SYNERGIES INC
TAOXFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$299K
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
β$9Mβ² +32.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$6Mβ² +30.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
7.4Mβ² +448.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$5MβΌ β$12M YoY
About TAO SYNERGIES INC
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
βοΈValuationβ
β
β
β
β
π§Dilutionβ
β
β
β
β
Overall Score
Insufficient data
β/100
Analyst Ratings
βConsensus
Buy
7 analysts
Strong Buy2
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Apr 2025
Latest News & Updates
News unavailable.